Percutaneous Transcatheter Aortic Valve Implantation: Assessing Results, Judging Outcomes, and Planning Trials. The Interventionalist Perspective

JACC: Cardiovascular Interventions

Volumn 1, Issue 4, 2008, Pages 341-350

  Chiam, Paul T L ^a   Ruiz, Carlos E ^a  

^a LENOX HILL HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

aortic valve stenosis; bioprosthesis; clinical trials; heart valve prosthesis implantation; percutaneous; surgery

Indexed keywords

AGING; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; CLINICAL TRIAL; COMORBIDITY; DISEASE SEVERITY; HIGH RISK PATIENT; HUMAN; MEDICAL TECHNOLOGY; METHODOLOGY; OUTCOMES RESEARCH; PATIENT SELECTION; PERCUTANEOUS AORTA VALVE REPLACEMENT; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SURGICAL RISK;

AGED; AORTIC VALVE STENOSIS; CLINICAL TRIALS AS TOPIC; DEVICE APPROVAL; EVIDENCE-BASED MEDICINE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; PRODUCT SURVEILLANCE, POSTMARKETING; PROSTHESIS DESIGN; RESEARCH DESIGN; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 49549121647     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.03.018     Document Type: Review

References (69)

1. Nkomo V.T., Gardin J.M., Skelton T.N., Gottdiener J.S., Scott C.G., and Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 368 (2006) 1005-1011
2. U.S. Census Bureau. United States Census 2000 (2001), U.S. Census Bureau, Washington, DC
3. Rahimtoola S.H. Perspective on valvular heart disease: an update. J Am Coll Cardiol 14 (1989) 1-23
4. Culliford A.T., Galloway A.C., Colvin S.B., et al. Aortic valve replacement for aortic stenosis in persons aged 80 years and over. Am J Cardiol 67 (1991) 1256-1260
5. Kvidal P., Bergstrom R., Horte L.G., and Stahle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 35 (2000) 747-756
6. Kvidal P., Bergstrom R., Malm T., and Stahle E. Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J 21 (2000) 1099-1111
7. Roques F., Nashef S.A., and Michel P. Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J Heart Valve Dis 10 (2001) 572-577 discussion 577-8
8. Logeais Y., Langanay T., Roussin R., et al. Surgery for aortic stenosis in elderly patients. A study of surgical risk and predictive factors. Circulation 90 (1994) 2891-2898
9. Cribier A., Savin T., Berland J., et al. Percutaneous transluminal balloon valvuloplasty of adult aortic stenosis: report of 92 cases. J Am Coll Cardiol 9 (1987) 381-386
10. McKay R.G. The Mansfield Scientific Aortic Valvuloplasty Registry: overview of acute hemodynamic results and procedural complications. J Am Coll Cardiol 17 (1991) 485-491
11. Block P.C., and Palacios I.F. Clinical and hemodynamic follow-up after percutaneous aortic valvuloplasty in the elderly. Am J Cardiol 62 (1988) 760-763
12. Otto C.M., Mickel M.C., Kennedy J.W., et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 89 (1994) 642-650
13. Kuntz R.E., Tosteson A.N., Berman A.D., et al. Predictors of event-free survival after balloon aortic valvuloplasty. N Engl J Med 325 (1991) 17-23
14. Bonow R.O., Carabello B.A., Kanu C., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48 (2006) e1-e148
15. Andersen H.R., Knudsen L.L., and Hasenkam J.M. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 13 (1992) 704-708
16. Bonhoeffer P., Boudjemline Y., Saliba Z., et al. Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation 102 (2000) 813-816
17. Boudjemline Y., and Bonhoeffer P. Steps toward percutaneous aortic valve replacement. Circulation 105 (2002) 775-778
18. Boudjemline Y., and Bonhoeffer P. Percutaneous implantation of a valve in the descending aorta in lambs. Eur Heart J 23 (2002) 1045-1049
19. Bonhoeffer P., Boudjemline Y., Saliba Z., et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 356 (2000) 1403-1405
20. Cribier A., Eltchaninoff H., Bash A., et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106 (2002) 3006-3008
21. Cribier A., Eltchaninoff H., Tron C., et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 43 (2004) 698-703
22. Grube E., Laborde J.C., Gerckens U., et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114 (2006) 1616-1624
23. Grube E., Laborde J.C., Zickmann B., et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv 66 (2005) 465-469
24. Hanzel G.S., Harrity P.J., Schreiber T.L., and O'Neill W.W. Retrograde percutaneous aortic valve implantation for critical aortic stenosis. Catheter Cardiovasc Interv 64 (2005) 322-326
25. Webb J.G., Chandavimol M., Thompson C.R., et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113 (2006) 842-850
26. Grube E., Schuler G., Buellesfeld L., et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50 (2007) 69-76
27. Webb J.G., Pasupati S., Humphries K., et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116 (2007) 755-763
28. Cribier A., Eltchaninoff H., Tron C., et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 47 (2006) 1214-1223
29. Paniagua D., Condado J.A., Besso J., et al. First human case of retrograde transcatheter implantation of an aortic valve prosthesis. Tex Heart Inst J 32 (2005) 393-398
30. Zegdi R., Khabbaz Z., Borenstein N., and Fabiani J.N. A repositionable valved stent for endovascular treatment of deteriorated bioprostheses. J Am Coll Cardiol 48 (2006) 1365-1368
31. Attmann T., Lutter G., Quaden R., et al. Percutaneous valve replacement: significance of different delivery systems in vitro and in vivo. Cardiovasc Intervent Radiol 29 (2006) 406-412
32. Roques F., Michel P., Goldstone A.R., and Nashef S.A. The logistic EuroSCORE. Eur Heart J 24 (2003) 881-882
33. Edwards F.H., Grover F.L., Shroyer A.L., Schwartz M., and Bero J. The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Ann Thorac Surg 63 (1997) 903-908
34. Wenaweser P., Buellesfeld L., Gerckens U., and Grube E. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the CoreValve Revalving system. Catheter Cardiovasc Interv 70 (2007) 760-764
35. Rallidis L.S., Moyssakis I.E., Ikonomidis I., and Nihoyannopoulos P. Natural history of early aortic paraprosthetic regurgitation: a five-year follow-up. Am Heart J 138 (1999) 351-357
36. Blais C., Dumesnil J.G., Baillot R., Simard S., Doyle D., and Pibarot P. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation 108 (2003) 983-988
37. Mohty D., Malouf J.F., Girard S.E., et al. Impact of prosthesis-patient mismatch on long-term survival in patients with small St. Jude Medical mechanical prostheses in the aortic position. Circulation 113 (2006) 420-426
38. Tasca G., Mhagna Z., Perotti S., et al. Impact of prosthesis-patient mismatch on cardiac events and midterm mortality after aortic valve replacement in patients with pure aortic stenosis. Circulation 113 (2006) 570-576
39. Galderisi M., Benjamin E.J., Evans J.C., et al. Intra- and interobserver reproducibility of Doppler-assessed indexes of left ventricular diastolic function in a population-based study (the Framingham Heart study). Am J Cardiol 70 (1992) 1341-1346
40. Smith M.D., Grayburn P.A., Spain M.G., and DeMaria A.N. Observer variability in the quantitation of Doppler color flow jet areas for mitral and aortic regurgitation. J Am Coll Cardiol 11 (1988) 579-584
41. Bauer F., Eltchaninoff H., Tron C., et al. Acute improvement in global and regional left ventricular systolic function after percutaneous heart valve implantation in patients with symptomatic aortic stenosis. Circulation 110 (2004) 1473-1476
42. Ferrari M., Figulla H.R., Schlosser M., et al. Transarterial aortic valve replacement with a self expanding stent in pigs. Heart 90 (2004) 1326-1331
43. Nordmeyer J., Khambadkone S., Coats L., et al. Risk stratification, systematic classification, and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation. Circulation 115 (2007) 1392-1397
44. Shephard R.J., and Franklin B. Changes in the quality of life: a major goal of cardiac rehabilitation. J Cardiopulm Rehabil 21 (2001) 189-200
45. Otto C.M. Timing of aortic valve surgery. Heart 84 (2000) 211-218
46. Guyatt G.H., Ferrans C.E., Halyard M.Y., et al. Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice. Mayo Clin Proc 82 (2007) 1229-1239
47. Edwards F.H., Peterson E.D., Coombs L.P., et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 37 (2001) 885-892
48. Roques F., Nashef S.A., Michel P., et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15 (1999) 816-822 discussion 822-3
49. Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., and Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16 (1999) 9-13
50. Lichtenstein S.V., Cheung A., Ye J., et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 114 (2006) 591-596
51. Walther T., Falk V., Borger M.A., et al. Minimally invasive transapical beating heart aortic valve implantation-proof of concept. Eur J Cardiothorac Surg 31 (2007) 9-15
52. Gammie J.S., Brown J.W., Brown J.M., et al. Aortic valve bypass for the high-risk patient with aortic stenosis. Ann Thorac Surg 81 (2006) 1605-1610
53. Grunkemeier G.L., Johnson D.M., and Naftel D.C. Sample size requirements for evaluating heart valves with constant risk events. J Heart Valve Dis 3 (1994) 53-58
54. Johnson D.M., and Sapirstein W. FDA's requirements for in-vivo performance data for prosthetic heart valves. J Heart Valve Dis 3 (1994) 350-355
55. Grunkemeier G.L., Jin R., and Starr A. Prosthetic heart valves: objective performance criteria versus randomized clinical trial. Ann Thorac Surg 82 (2006) 776-780
56. Karthik S., Srinivasan A.K., Grayson A.D., et al. Limitations of additive EuroSCORE for measuring risk stratified mortality in combined coronary and valve surgery. Eur J Cardiothorac Surg 26 (2004) 318-322
57. Nashef S.A., Roques F., Hammill B.G., et al. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 22 (2002) 101-105
58. Geissler H.J., Holzl P., Marohl S., et al. Risk stratification in heart surgery: comparison of six score systems. Eur J Cardiothorac Surg 17 (2000) 400-406
59. Nilsson J., Algotsson L., Hoglund P., Luhrs C., and Brandt J. Early mortality in coronary bypass surgery: the EuroSCORE versus The Society of Thoracic Surgeons risk algorithm. Ann Thorac Surg 77 (2004) 1235-1239 discussion 1239-40
60. Nilsson J., Algotsson L., Hoglund P., Luhrs C., and Brandt J. Comparison of 19 pre-operative risk stratification models in open-heart surgery. Eur Heart J 27 (2006) 867-874
61. Ambler G., Omar R.Z., Royston P., Kinsman R., Keogh B.E., and Taylor K.M. Generic, simple risk stratification model for heart valve surgery. Circulation 112 (2005) 224-231
62. Dewey T.M., Brown D., Ryan W.H., Herbert M.A., Prince S.L., and Mack M.J. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 135 (2008) 180-187
63. Vassiliades Jr. T.A., Block P.C., Cohn L.H., et al. The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI) endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA). J Am Coll Cardiol 45 (2005) 1554-1560
64. DeMaria A.N. Clinical trials and clinical judgment. J Am Coll Cardiol 51 (2008) 1120-1122
65. Chen E., Sapirstein W., Ahn C., Swain J., and Zuckerman B. FDA perspective on clinical trial design for cardiovascular devices. Ann Thorac Surg 82 (2006) 773-775
66. Grunkemeier G.L., and Payne N. Bayesian analysis: a new statistical paradigm for new technology. Ann Thorac Surg 74 (2002) 1901-1908
67. D'Agostino Jr. R.B. Propensity scores in cardiovascular research. Circulation 115 (2007) 2340-2343
68. Sapirstein W. Designing trials for testing prosthetic cardiac valves: a Food and Drug Administration perspective. Am Heart J 141 (2001) 861-863
69. U.S. Food and Drug Administration. Center for Devices and Radiological Health. Post Approval Studies. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma_pas.cfm Accessed December 28, 2007